Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29226 - 29250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	PTX3	5806	downregulated	Dasatinib results in decreased expression of PTX3 mRNA	3q25.32	A21899
Dasatinib	Approved Investigational	RACGAP1	29127	downregulated	Dasatinib results in decreased expression of RACGAP1 mRNA	12q13.12	A21899
Dasatinib	Approved Investigational	RAD51	5888	downregulated	Dasatinib results in decreased expression of RAD51 mRNA	15q15.1	A21899
Dasatinib	Approved Investigational	RASSF2	9770	upregulated	Dasatinib results in increased expression of RASSF2 mRNA	20p13	A21899
Dasatinib	Approved Investigational	RAVER2	55225	upregulated	Dasatinib results in increased expression of RAVER2 mRNA	1p31.3	A21899
Dasatinib	Approved Investigational	RDH10	157506	upregulated	Dasatinib results in increased expression of RDH10 mRNA	8q21.11	A21899
Dasatinib	Approved Investigational	RECK	8434	upregulated	Dasatinib results in increased expression of RECK mRNA	9p13.3	A21899
Dasatinib	Approved Investigational	RFC2	5982	downregulated	Dasatinib results in decreased expression of RFC2 mRNA	7q11.23	A21899
Dasatinib	Approved Investigational	RFC3	5983	downregulated	Dasatinib results in decreased expression of RFC3 mRNA	13q13.2	A21899
Dasatinib	Approved Investigational	RFC4	5984	downregulated	Dasatinib results in decreased expression of RFC4 mRNA	3q27.3	A21899
Dasatinib	Approved Investigational	RFC5	5985	downregulated	Dasatinib results in decreased expression of RFC5 mRNA	12q24.23	A21899
Dasatinib	Approved Investigational	RFWD3	55159	downregulated	Dasatinib results in decreased expression of RFWD3 mRNA	16q23.1	A21899
Dasatinib	Approved Investigational	RFX8	731220	downregulated	Dasatinib results in decreased expression of RFX8 mRNA	2q11.2	A21899
Dasatinib	Approved Investigational	RGMB	285704	downregulated	Dasatinib results in decreased expression of RGMB mRNA	5q15	A21899
Dasatinib	Approved Investigational	RGS4	5999	downregulated	Dasatinib results in decreased expression of RGS4 mRNA	1q23.3	A21899
Dasatinib	Approved Investigational	RNASEH2A	10535	downregulated	Dasatinib results in decreased expression of RNASEH2A mRNA	19p13.13	A21899
Dasatinib	Approved Investigational	RNU5F-1	26828	downregulated	Dasatinib results in decreased expression of RNU5F-1 mRNA	1p34.1	A21899
Dasatinib	Approved Investigational	ROR1	4919	upregulated	Dasatinib results in increased expression of ROR1 mRNA	1p31.3	A21899
Dasatinib	Approved Investigational	RPSAP52	204010	downregulated	Dasatinib results in decreased expression of RPSAP52 mRNA	12q14.3	A21899
Dasatinib	Approved Investigational	RRM1	6240	downregulated	Dasatinib results in decreased expression of RRM1 mRNA	11p15.4	A21899
Dasatinib	Approved Investigational	RRM2	6241	downregulated	Dasatinib results in decreased expression of RRM2 mRNA	2p25.1	A21899
Dasatinib	Approved Investigational	SDC2	6383	upregulated	Dasatinib results in increased expression of SDC2 mRNA	8q22.1	A21899
Dasatinib	Approved Investigational	SELENOP	6414	upregulated	Dasatinib results in increased expression of SELENOP mRNA	5p12	A21899
Dasatinib	Approved Investigational	SEMA3A	10371	downregulated	Dasatinib results in decreased expression of SEMA3A mRNA	7q21.11	A21899
Dasatinib	Approved Investigational	SERPINB2	5055	downregulated	Dasatinib results in decreased expression of SERPINB2 mRNA	18q21.33-q22.1	A21899

Displaying entries 29226 - 29250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability